EMPHYSEMA OF EARLY ONSET ASSOCIATED WITH A COMPLETE DEFICIENCY OF ALPHA-1-ANTITRYPSIN (NULL HOMOZYGOTES)
EMPHYSEMA OF EARLY ONSET ASSOCIATED WITH A COMPLETE DEFICIENCY OF ALPHA-1-ANTITRYPSIN (NULL HOMOZYGOTES)
复制标题
DOI:
10.1164/ajrccm/137.2.371
复制
发表时间:
1988-02-01
期刊:
影响因子:
--
通讯作者:
LEVISON, H
中科院分区:
文献类型:
--
作者:
COX, DW;LEVISON, H
We have compared lung function in 3 subjects with no .alpha.1-antitrypsin (.alpha.1-protease inhibitor) (null homozygotes) with subjects having the typical deficiency, PI ZZ. We identified a 31-yr-old woman, presenting with severe obstructive lung disease, who had no detectable plasma .alpha.1-antitrypsin, indicating homozygosity for a "null" (or Pl*QO) allele of .alpha.1-antitrypsin. Two of her sisters have a similar deficiency, one with an onset of symptoms at 17 yr of age. Because of the likelihood that there are a number of different Pl*QO alleles, the type in this family has been named null Mattawa(QOmattawa). All 3 homozygotes have shown a marked deterioration of lung function over a 7-yr period of follow-up. In contrast, lung function tests of 6 age-matched nonsmoking subjects with .alpha.1-antitrypsin deficiency, Pl type ZZ, showed no abnormalities of lung function. The 15 to 20% of the normal plasma concentration of .alpha.1-antitrypsin associated with the Pl*Z allele appears to provide some protection to the lung in comparison with a complete deficiency state.